MATES SHARON (Chairman, President & CEO) exercised options at INTRA-CELLULAR THERAPIES, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 2 exercises
Filed: 3/10/2025ACC: 0000950170-25-036593
DirectorOfficer· Chairman, President & CEO
Since Dec 2018
-29.98K
Net shares
Net seller
$3.93M
Total sold
0
Open market trades
0B · 0S
6
Total transactions
61.28K acquired · 91.25K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+40.71K
Price / share
—
Trade value
—
% of position
3.7%
3/6/2025
1.10M→1.14M
Common Stock
Direct
Shares
−19.85K
Price / share
$131.19
Trade value
$2.60M
% of position
1.7%
3/6/2025
1.14M→1.12M
Common Stock
Direct
Shares
+20.57K
Price / share
—
Trade value
—
% of position
1.8%
3/10/2025
1.12M→1.15M
Common Stock
Direct
Shares
−10.13K
Price / share
$131.24
Trade value
$1.33M
% of position
0.9%
3/10/2025
1.15M→1.14M
Total
Net shares
+31.30K
Net value
-$3.93M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2025 | M · Option Exercise | +40.71K | — | — | 3.7% | 1.10M | 1.14M |
| Common Stock Direct | 3/6/2025 | F · Tax Withholding | −19.85K | $131.19 | $2.60M | 1.7% | 1.14M | 1.12M |
| Common Stock Direct | 3/10/2025 | M · Option Exercise | +20.57K | — | — | 1.8% | 1.12M | 1.15M |
| Common Stock Direct | 3/10/2025 | F · Tax Withholding | −10.13K | $131.24 | $1.33M | 0.9% | 1.15M | 1.14M |
| Total | +31.30K | -$3.93M | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
40.71K shares
Shares
−40.71K
Strike price
Held after
40.71K
Exercisable
—
3/6/2025
Restricted Stock Units
Direct
Converts to
Common Stock
20.57K shares
Shares
−20.57K
Strike price
Held after
0.00
Exercisable
—
3/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock40.71K shares | 3/6/2025 | M · Option Exercise | −40.71K | — | 40.71K | |
| Restricted Stock Units Direct | Common Stock20.57K shares | 3/10/2025 | M · Option Exercise | −20.57K | — | 0.00 |